GSH Response


GSH response copolymers have gained significant attention in the field of drug delivery due to their ability to selectively release drugs in GSH-rich environments, such as tumor cells. This targeted drug delivery approach holds the potential to enhance the therapeutic efficacy of anticancer drugs while minimizing their systemic toxicity. When the GSH response copolymer reaches the target tissue or cell, which is often characterized by higher GSH levels compared to healthy tissue, the presence of GSH triggers the cleavage or disassembly of the copolymer structure. This cleavage event can lead to the release of the encapsulated drug or detachment of the drug from the copolymer backbone, thereby achieving site-specific drug delivery.

DSPE-SS-PEG-COOH

Catalog: CDA24-098-L

PEG MW: 1K Da, 2K Da, 5K Da, 10K Da, 20K Da

DSPE-SS-PEG-DBCO

Catalog: PHRC290

MW: N/A

DSPE-SS-PEG-NH2

Catalog: CDA24-099-L

PEG MW: 1K Da, 2K Da, 3.4K Da, 5K Da, 10K Da

DSPE-SS-PEG-NHS

Catalog: PHRC292

MW: N/A

Fmoc-NHS-SS-PEG-NHS

Catalog: PHRC312

MW: N/A

HA-SS-FITC Hyaluronic

Catalog: PHRC389

MW: N/A

HA-SS-PEG

Catalog: PHRC392

MW: N/A

Hyaluronate-SS-DOPE

Catalog: PHRC396

MW: N/A

Hyaluronate-SS-DOX

Catalog: PHRC398

MW: N/A

Hyaluronate-SS-DSPE

Catalog: PHRC402

MW: N/A

Hyaluronate-SS-PCL

Catalog: PHRC404

MW: N/A

Hyaluronate-SS-PLA

Catalog: PHRC407

MW: N/A

Hyaluronate-SS-PLGA

Catalog: PHRC410

MW: N/A

Hyaluronate-SS-PLL

Catalog: PHRC413

MW: N/A

Hyaluronate-SS-PTX

Catalog: PHRC400

MW: N/A

ICG@HESSS-DOX

Catalog: PHRC415

MW: N/A

iRGD-HESSS-C18

Catalog: PHRC417

MW: N/A

K5-SS-DOCA,K5

Catalog: PHRC419

MW: N/A

MPEG-PCL-SS-TAT

Catalog: PHRC421

MW: N/A

mPEG-SS-COOH

Catalog: PHRC327

MW: N/A

Products
Fill out the form below
to receive a quote

GET A QUOTE

  • (USA)
  • (Europe)
Cookie Policy | Privacy Policy | Copyright © 2024 CD Bioparticles. All rights reserved.
0
Inquiry Basket
Inquiry